Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Keratin 17 gene mutations cause both steatocystoma multiplex and pachyonychia congenita type 2.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Injecting specific oligonucleotides can change hair growth and structure by altering a gene.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.